Point of Care Fibrinogen Measurement in Trauma Patients in the Emergency Department

Recruiting Observational Study
Trauma Induced Coagulopathy Trauma Coagulopathy Fibrinogen Deficiency Fibrinogen; Deficiency, Acquired Massive Transfusion Protocol Massive Hemorrhage
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
16 and older
Sex
Any
Study type
Observational
Participants needed
150 (estimated)
Sponsor
Erasmus Medical Center · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Background: Why This Study Matters When someone suffers a severe injury (like from a car crash), they can bleed heavily. One complication doctors often face is something called Trauma-Induced Coagulopathy (TIC). This is a condition where the blood doesn't clot properly, making bleeding worse. The reasons behind TIC are complicated and not fully understood. One important substance involved is fibr…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Population (base) Adult trauma patients will be identified as follows: (1) by the trauma team leader on admission to the ED or (2) by the research team personnel following a massive transfusion protocol activation. Patients will be assessed for eligibility to enter the trial according to the criteri…
Contacts

Niki A. Ottenhof, MD, PhD

+31-10-70-41277

n.ottenhof@erasmusmc.nl

CONTACT